Capital Research Global Investors Novartis Ag Transaction History

Capital Research Global Investors

  • $466 Billion
  • Q4 2024

A detailed history of Capital Research Global Investors transactions in Novartis Ag stock. As of the latest transaction made, Capital Research Global Investors holds 907,138 shares of NVS stock, worth $98 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
907,138
Previous 905,435 0.19%
Holding current value
$98 Million
Previous $104 Million 15.24%
% of portfolio
0.02%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$96.78 - $117.18 $164,816 - $199,557
1,703 Added 0.19%
907,138 $88.3 Million
Q3 2024

Nov 13, 2024
BUY
$106.13 - $120.89 $138,711 - $158,003
1,307 Added 0.14%
905,435 $104 Million
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $555 - $644
-6 Reduced -0.0%
904,128 $96.3 Million
Q1 2024

May 14, 2024
BUY
$95.27 - $108.47 $39,251 - $44,689
412 Added 0.05%
904,134 $87.5 Million
Q4 2023

Feb 13, 2024
BUY
$92.27 - $101.54 $9,688 - $10,661
105 Added 0.01%
903,722 $91.2 Million
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $35,429 - $39,318
374 Added 0.04%
903,617 $92 Million
Q2 2023

Aug 11, 2023
BUY
$92.52 - $104.91 $37,748 - $42,803
408 Added 0.05%
903,243 $91.1 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $6.53 Million - $7.57 Million
-81,573 Reduced 8.29%
902,835 $83.1 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $25,591 - $29,930
-343 Reduced 0.03%
984,408 $74.8 Million
Q2 2022

Aug 15, 2022
SELL
$80.52 - $93.75 $29,228 - $34,031
-363 Reduced 0.04%
984,751 $83.2 Million
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $6.61 Million - $7.47 Million
82,458 Added 9.14%
985,114 $86.4 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $30,604 - $33,841
-384 Reduced 0.04%
902,656 $79 Million
Q3 2021

Nov 15, 2021
BUY
$81.78 - $95.14 $26,169 - $30,444
320 Added 0.04%
903,040 $73.9 Million
Q2 2021

Aug 16, 2021
SELL
$85.24 - $94.15 $125 Million - $138 Million
-1,463,025 Reduced 61.84%
902,720 $82.4 Million
Q1 2021

May 14, 2021
BUY
$83.5 - $98.47 $205,827 - $242,728
2,465 Added 0.1%
2,365,745 $202 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $35.5 Million - $43 Million
455,234 Added 23.86%
2,363,280 $223 Million
Q3 2020

Nov 13, 2020
BUY
$82.14 - $91.0 $13.8 Million - $15.3 Million
167,613 Added 9.63%
1,908,046 $166 Million
Q2 2020

Aug 14, 2020
BUY
$80.93 - $91.1 $176,427 - $198,598
2,180 Added 0.13%
1,740,433 $152 Million
Q1 2020

May 15, 2020
SELL
$70.67 - $99.01 $12.3 Million - $17.3 Million
-174,382 Reduced 9.12%
1,738,253 $143 Million
Q4 2019

Feb 18, 2020
BUY
$84.35 - $95.37 $323,819 - $366,125
3,839 Added 0.2%
1,912,635 $181 Million
Q3 2019

Nov 14, 2019
BUY
$85.54 - $94.26 $572,005 - $630,316
6,687 Added 0.35%
1,908,796 $166 Million
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $26.5 Million - $32.7 Million
352,024 Added 22.71%
1,902,109 $174 Million
Q1 2019

May 15, 2019
BUY
$75.32 - $86.15 $75 - $86
1 Added 0.0%
1,550,085 $149 Million
Q3 2018

Nov 14, 2018
SELL
$66.94 - $77.43 $200 - $232
-3 Reduced -0.0%
1,550,084 $134 Million
Q2 2018

Aug 14, 2018
BUY
$64.91 - $73.36 $4,608 - $5,208
71 Added 0.0%
1,550,087 $117 Million
Q1 2018

May 15, 2018
SELL
$70.39 - $84.15 $49.9 Million - $59.6 Million
-708,499 Reduced 31.37%
1,550,016 $125 Million
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $167 Million - $175 Million
2,258,515
2,258,515 $194 Million

Others Institutions Holding NVS

# of Institutions
1,474
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $232B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email